|
業務類別
|
-- |
|
業務概覽
|
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its main products include OvaWatch, Ova1Plus, Ova1, and Overa, which are used to assess ovarian cancer risk in women with adnexal masses. The company is also developing EndoCheck for endometriosis. The company views its operations and manages its business in a single operating segment, which is the discovery, development, and commercialization of noninvasive diagnostic tests. |
| 公司地址
| 12117 Bee Caves Road, Suite 100, Building 3, Austin, TX, USA, 78738 |
| 電話號碼
| +1 512 519-0400 |
| 傳真號碼
| +1 866 283-3634 |
| 公司網頁
| https://www.aspirawh.com |
| 員工數量
| 38 |
| Ms. Julie Carrillo |
Corporate Controller and Interim Principal Accounting Officer |
-- |
08/04/2025 |
| Mr. Michael Buhle |
Chief Commercial Officer and Chief Executive Officer |
-- |
31/01/2025 |
|
|
| Mr. John Phillip Ragard |
Director |
11/04/2025 |
| Ms. Lynn O’Connor Vos |
Independent Director |
11/04/2025 |
| Dr. Jeffrey Cohen, M.D. |
Director |
08/04/2025 |
| Ms. Ellen Beausang |
Director |
10/02/2025 |
| Ms. Cynthia Hundorfean |
Director |
08/04/2025 |
| Dr. Winfred Parnell, M.D. |
Independent Director |
11/04/2025 |
| Ms. Jannie Herchuk |
Chairman of the Board |
11/04/2025 |
| Mr. John Fraser |
Director |
08/04/2025 |
| Ms. Stefanie Cavanaugh |
Independent Director |
11/04/2025 |
|
|
|
|
